If you cant get a GLP-1 for weight loss, what are your options
With so little direct research, clinical guidelines often lean on what we can reasonably assume from the medication design and its composition, like its size, how the body absorbs it, and how likely it is to pass into breast milk, instead of real-world studies in breastfeeding mothers and babies
Findings The researchers did not detect semaglutide in milk samples collected 0, 12, and 24 after drug administration
It is backed by third-party testing and NSF-certified manufacturing, while product-specific testing is not currently verified by SuppCo
10.1073/pnas.1801109115 236 MejziniR.FlynnL
Zepbound (tirzepatide) is a dual GLP-1/GIP agonist that typically produces even stronger appetite suppression than semaglutide-based drugs, making adequate protein intake especially critical